Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mathias Lichterfeld, Ph.D., M.D.

Co-Author

This page shows the publications co-authored by Mathias Lichterfeld and Eric Rosenberg.
Connection Strength

4.261
  1. Acute HIV-1 infection: a call to action. Ann Intern Med. 2013 Sep 17; 159(6):425-7.
    View in: PubMed
    Score: 0.571
  2. Antiretroviral combination therapy markedly reduces risk of heterosexual HIV-1 transmission. Evid Based Med. 2012 Jun; 17(3):95-6.
    View in: PubMed
    Score: 0.503
  3. Intact HIV-1 proviruses accumulate at distinct chromosomal positions during prolonged antiretroviral therapy. J Clin Invest. 2019 03 01; 129(3):988-998.
    View in: PubMed
    Score: 0.207
  4. Anti-apoptotic Protein BIRC5 Maintains Survival of HIV-1-Infected CD4+ T Cells. Immunity. 2018 06 19; 48(6):1183-1194.e5.
    View in: PubMed
    Score: 0.197
  5. Preferential susceptibility of Th9 and Th2 CD4+ T cells to X4-tropic HIV-1 infection. AIDS. 2017 10 23; 31(16):2211-2215.
    View in: PubMed
    Score: 0.190
  6. Clonal expansion of genome-intact HIV-1 in functionally polarized Th1 CD4+ T cells. J Clin Invest. 2017 Jun 30; 127(7):2689-2696.
    View in: PubMed
    Score: 0.185
  7. Th1/17 Polarization of CD4 T Cells Supports HIV-1 Persistence during Antiretroviral Therapy. J Virol. 2015 Nov; 89(22):11284-93.
    View in: PubMed
    Score: 0.163
  8. Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells. J Virol. 2014 Sep 01; 88(17):10056-65.
    View in: PubMed
    Score: 0.151
  9. HIV-1 persistence in CD4+ T cells with stem cell-like properties. Nat Med. 2014 Feb; 20(2):139-42.
    View in: PubMed
    Score: 0.146
  10. Susceptibility to CD8 T-cell-mediated killing influences the reservoir of latently HIV-1-infected CD4 T cells. . 2014 Jan 01; 65(1):1-9.
    View in: PubMed
    Score: 0.146
  11. CD4 T-cell regeneration in HIV-1 elite controllers. AIDS. 2012 Mar 27; 26(6):701-6.
    View in: PubMed
    Score: 0.129
  12. Shelterin dysfunction and p16(INK4a)-mediated growth inhibition in HIV-1-specific CD8 T cells. J Virol. 2012 May; 86(10):5533-40.
    View in: PubMed
    Score: 0.128
  13. Inhibition of HIV-1 integration in ex vivo-infected CD4 T cells from elite controllers. J Virol. 2011 Sep; 85(18):9646-50.
    View in: PubMed
    Score: 0.123
  14. CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21. J Clin Invest. 2011 Apr; 121(4):1549-60.
    View in: PubMed
    Score: 0.120
  15. Transcriptional profiling of CD4 T cells identifies distinct subgroups of HIV-1 elite controllers. J Virol. 2011 Mar; 85(6):3015-9.
    View in: PubMed
    Score: 0.118
  16. Epigenetic regulation of telomerase expression in HIV-1-specific CD8+ T cells. AIDS. 2010 Jul 31; 24(12):1964-6.
    View in: PubMed
    Score: 0.115
  17. Telomerase activity of HIV-1-specific CD8+ T cells: constitutive up-regulation in controllers and selective increase by blockade of PD ligand 1 in progressors. Blood. 2008 Nov 01; 112(9):3679-87.
    View in: PubMed
    Score: 0.101
  18. A viral CTL escape mutation leading to immunoglobulin-like transcript 4-mediated functional inhibition of myelomonocytic cells. J Exp Med. 2007 Nov 26; 204(12):2813-24.
    View in: PubMed
    Score: 0.095
  19. Selective depletion of high-avidity human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T cells after early HIV-1 infection. J Virol. 2007 Apr; 81(8):4199-214.
    View in: PubMed
    Score: 0.090
  20. T cell receptor cross-recognition of an HIV-1 CD8+ T cell epitope presented by closely related alleles from the HLA-A3 superfamily. Int Immunol. 2006 Jul; 18(7):1179-88.
    View in: PubMed
    Score: 0.086
  21. Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells. J Exp Med. 2004 Sep 20; 200(6):701-12.
    View in: PubMed
    Score: 0.077
  22. HIV-1 Nef is preferentially recognized by CD8 T cells in primary HIV-1 infection despite a relatively high degree of genetic diversity. AIDS. 2004 Jul 02; 18(10):1383-92.
    View in: PubMed
    Score: 0.075
  23. Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides. J Virol. 2004 May; 78(9):4463-77.
    View in: PubMed
    Score: 0.075
  24. HIV-1-specific cytotoxicity is preferentially mediated by a subset of CD8(+) T cells producing both interferon-gamma and tumor necrosis factor-alpha. Blood. 2004 Jul 15; 104(2):487-94.
    View in: PubMed
    Score: 0.074
  25. Immune-profiling of ZIKV-infected patients identifies a distinct function of plasmacytoid dendritic cells for immune cross-regulation. Nat Commun. 2020 05 15; 11(1):2421.
    View in: PubMed
    Score: 0.057
  26. Transcriptional Changes during Naturally Acquired Zika Virus Infection Render Dendritic Cells Highly Conducive to Viral Replication. Cell Rep. 2017 Dec 19; 21(12):3471-3482.
    View in: PubMed
    Score: 0.048
  27. Prolonged Antiretroviral Therapy Preserves HIV-1-Specific CD8 T Cells with Stem Cell-Like Properties. J Virol. 2015 Aug; 89(15):7829-40.
    View in: PubMed
    Score: 0.040
  28. Functional characterization of HLA-G? regulatory T cells in HIV-1 infection. PLoS Pathog. 2013 Jan; 9(1):e1003140.
    View in: PubMed
    Score: 0.034
  29. Dendritic cell dysfunction during primary HIV-1 infection. J Infect Dis. 2011 Nov 15; 204(10):1557-62.
    View in: PubMed
    Score: 0.031
  30. Recognition of a defined region within p24 gag by CD8+ T cells during primary human immunodeficiency virus type 1 infection in individuals expressing protective HLA class I alleles. J Virol. 2007 Jul; 81(14):7725-31.
    View in: PubMed
    Score: 0.023
  31. Mutually exclusive T-cell receptor induction and differential susceptibility to human immunodeficiency virus type 1 mutational escape associated with a two-amino-acid difference between HLA class I subtypes. J Virol. 2007 Feb; 81(4):1619-31.
    View in: PubMed
    Score: 0.022
  32. HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1. PLoS Med. 2006 Oct; 3(10):e403.
    View in: PubMed
    Score: 0.022
  33. De novo generation of escape variant-specific CD8+ T-cell responses following cytotoxic T-lymphocyte escape in chronic human immunodeficiency virus type 1 infection. J Virol. 2005 Oct; 79(20):12952-60.
    View in: PubMed
    Score: 0.021
  34. HLA-B63 presents HLA-B57/B58-restricted cytotoxic T-lymphocyte epitopes and is associated with low human immunodeficiency virus load. J Virol. 2005 Aug; 79(16):10218-25.
    View in: PubMed
    Score: 0.020
  35. Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection. Blood. 2005 Nov 15; 106(10):3366-9.
    View in: PubMed
    Score: 0.020
  36. The majority of currently circulating human immunodeficiency virus type 1 clade B viruses fail to prime cytotoxic T-lymphocyte responses against an otherwise immunodominant HLA-A2-restricted epitope: implications for vaccine design. J Virol. 2005 Apr; 79(8):5000-5.
    View in: PubMed
    Score: 0.020
  37. Limited durability of viral control following treated acute HIV infection. PLoS Med. 2004 Nov; 1(2):e36.
    View in: PubMed
    Score: 0.019
  38. Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection. J Virol. 2004 Jul; 78(13):7069-78.
    View in: PubMed
    Score: 0.019
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.